Sudeep Pharma IPO Lists on BSE, NSE Today
Sudeep Pharma makes its stock market debut today. With a GMP of ₹121, the IPO is set for 20% listing gains after a blockbuster 93.72 times subscription. Get all the live details.
Category : Search result: smallcap pharma stock
Sudeep Pharma IPO Listing on Nov 28 with Strong GMP
Sudeep Pharma IPO makes Dalal Street debut on November 28. Grey market premium hits ₹100, signaling 15% listing gain. Discover subscription details and key facts.
BSE Smallcap Company to Raise Funds via Foreign Currency Bonds
A BSE-listed smallcap company announces plans to consider fundraising through foreign currency bonds. Key board meeting scheduled for November 26, 2024. Details inside.
Sudeep Pharma IPO Allotment Today: Check Status Now
Sudeep Pharma IPO allotment likely on November 26. Learn how to check allotment status via BSE, NSE, registrar. Strong 93.72x subscription signals investor confidence.
Small-Cap Stocks Crash 60% in 2025 Market Rout
Nifty Smallcap 100 index drops 6% in 2025 as poor earnings and rich valuations trigger massive selloff. Tejas Networks, FirstCry among top losers falling 40-60%. Discover why investors are shifting to large-caps.
Sudeep Pharma IPO Subscribed 5.09x, Closes Nov 25
Sudeep Pharma IPO sees massive 5.09x subscription on Day 2. Grey market premium hits ₹86. Allotment scheduled for November 26. Apply before closing tomorrow!
Lupin: Undervalued Pharma Giant at 21x P/E?
Lupin stocks trade at 21.7x P/E despite record earnings and 80 new products pipeline. Discover why this pharma giant might be undervalued and poised for next growth cycle with biosimilars and complex generics.
Sudeep Pharma IPO Day 2: GMP Signals Strong Gains
Sudeep Pharma's ₹895 crore IPO is fully subscribed. With a GMP of ₹121, investors eye a 20% listing gain. Track all live updates here.
Sudeep Pharma IPO Fully Subscribed on Day 1
Sudeep Pharma's IPO concludes November 25 after strong第一天 response. Grey market premium hits ₹121, signaling 20% listing gains. Key dates and subscription details revealed.
Market Split: Large Caps Gain While Mid, Small Caps Fall
Indian markets show mixed trends with large caps attracting buyers while broader markets face selling pressure. Midcap and Smallcap indices fell significantly. Explore the sectoral performance and market outlook.
Eli Lilly First Pharma to Reach $1 Trillion Market Cap
Eli Lilly makes pharmaceutical history as first company to achieve $1 trillion market capitalization after shares rose 1.7% on November 21, 2025. Learn what this means for investors.
Smallcap Pharma Stock Gains 10% Despite Market Sell-Off
A smallcap pharma stock listed on NSE defied market trends with a 10% surge on November 21, 2024. Discover the driving factors behind this remarkable performance.
Globe Civil Projects Share Jumps 5% on Court Win
Globe Civil Projects share price surged over 5% after Delhi court dismissed ₹23.81 lakh recovery suit. Smallcap stock defies weak market trend. Read full analysis.
Sudeep Pharma IPO: ₹895 Cr Offer Opens, ₹130 Grey Market Premium
Sudeep Pharma's ₹895 crore IPO opens with ₹563-593 price band. Grey market shows ₹130 premium. Analysts recommend long-term investment for 2-5 years horizon.
Sudeep Pharma IPO: ₹895 Crore Offer Opens Today
Sudeep Pharma's ₹895 crore IPO opens today. Price band ₹563-593 per share. Learn about company details, investment minimums & global presence. Subscribe now!
3 Smallcaps Benefiting from Railway Modernization
Discover 3 smallcap companies with strong order books and growing profits as Indian Railways accelerates modernization, electrification and safety upgrades. Investment insights included.
IT Firm Signs MOU with Andhra Pradesh Economic Development Board
A BSE-listed smallcap IT company signs strategic MOU with Andhra Pradesh Economic Development Board for digital transformation initiatives. Stock gains investor attention.
Smallcaps Remain Strong Despite Market Volatility: SAMCO CEO
Viraj Gandhi of SAMCO Mutual Fund explains why smallcaps remain compelling long-term investments despite recent volatility. Discover insights on market outlook and new momentum-based fund.
Sudeep Pharma IPO: 22% GMP, Opens Nov 21
Sudeep Pharma's ₹95 crore IPO opens November 21 with strong grey market premium. Learn price band, dates, financials & investment details for this pharma ingredients maker.
Sudeep Pharma IPO: ₹895 Cr Issue Opens Nov 21
Sudeep Pharma's ₹895 crore IPO opens November 21-25. Price band ₹563-593 per share. Company manufactures pharmaceutical excipients and speciality ingredients.
Sudeep Pharma IPO: Price Band ₹563-593 Per Share
Sudeep Pharma IPO opens November 21 with price band ₹563-593 per share. Company aims to raise ₹95 crore. Learn key dates, financials, and investment details.
Remedium Lifecare Q2 Profit Jumps 92% to ₹38.62 Cr
Remedium Lifecare reports stellar Q2 results with profit nearly doubling to ₹38.62 crore. Revenue surges 22% driven by strong pharmaceutical exports and domestic growth.
Smallcap Stock Rallies 10% Post Q2 Results, ₹2.5 Cr Profit
Shares of Kalyani Cast Tech surged 10% after reporting Q2 FY25 results with ₹2.5 crore net profit and ₹21.5 crore revenue. Discover the driving factors behind this rally.
European Pharma Stocks Rebound from AI Shift
European weight-loss drug makers surge as investors rotate capital from expensive AI stocks into healthcare. Zealand Pharma leads with a 20% weekly jump. Explore the market dynamics.
Purdue Pharma Wins Bankruptcy Approval in Opioid Case
Purdue Pharma receives court approval for $7.4 billion opioid settlement after Supreme Court intervention. Sackler family to pay $6.5 billion over 15 years in landmark case.
Purdue Pharma $7B Opioid Settlement Gets Court Nod
Federal judge approves Purdue Pharma's bankruptcy plan requiring Sackler family to pay $7 billion and surrender company ownership. Thousands of opioid victims to receive compensation in historic settlement.
Lincoln Pharma Aims for Rs 1000 Crore Revenue
Lincoln Pharmaceuticals Ltd announces ambitious plan to achieve Rs 1000 crore revenue within three years through strategic expansion and new product launches. Read more about their growth strategy.
OneSource Pharma Raises FY28 Revenue Target to $500M
OneSource Pharma hikes FY28 revenue guidance to over $500 million, plans $100M expansion for weight-loss drugs like semaglutide. CEO reveals accelerated growth strategy.
Gujarat Pharma Factory Blast: 2 Dead, 20 Injured
Tragic boiler explosion at pharmaceutical factory in Gujarat's Bharuch district claims 2 lives, leaves 20 injured. Massive fire brought under control by emergency teams.
India's Drug Regulator Tightens Pharma Quality Control
India's DCGI orders nationwide inspections of small pharma units as WHO flags toxic cough syrups. MSMEs struggle to meet new Schedule M compliance deadline of January 2026.
Page 2 of 4